Differential reactivity of active sites in human plasma cholinesterase toward 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Human plasma cholinesterase was found to be inhibited by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide in a biphasic manner. The faster phase of the inhibition led to loss of approximately 50% of the activity (measured at pH 7.0, 30 degrees C, using 2.5 mM butyrylthiocholine) and was irreversible. Inhibition in the slower phase was reversible by 0.25 M hydroxylamine. The protective effect of 1 mM propranolol indicated that the target residue in both phases was localized at the active site. Lineweaver-Burk plots for butyrylthiocholine were obtained at different times during the course of inactivation. It was found that for both native and partially inactivated enzymes the plots could be analyzed in terms of two activities showing hyperbolic saturation with the substrate, with Km values of 0.055 +/- 0.015 and 2.0 +/- 0.2 mM. The carbodiimide affected the maximal velocities of the component activities, leaving the Km's unchanged. The low-Km component was lost in the first phase of the inactivation. The loss of the high-Km component paralleled the second phase. It was concluded that the active sites in the tetrameric enzyme form two classes, differing in their affinity for butyrylthiocholine and their susceptibility to inhibition by the active site-directed carbodiimide.
D001665:Binding Sites / Q000187:drug effects; D002234:Carbodiimides / Q000494:pharmacology*; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D002802:Cholinesterases / Q000097:blood*; D005022:Ethyldimethylaminopropyl Carbodiimide / Q000494:pharmacology*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D019811:Hydroxylamine; D006898:Hydroxylamines / Q000494:pharmacology; D007700:Kinetics
D002234:Carbodiimides; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D006898:Hydroxylamines; D019811:Hydroxylamine; D002802:Cholinesterases; D005022:Ethyldimethylaminopropyl Carbodiimide